Latest News

The Injective's price could benefit from the changing market trends, especially if INJ holders act in accordance with the bullish cues.

Injective's July Community Update details significant milestones, including the success of the Injective (INJ)Builder House during EthCC.

Injective, a Layer 1 blockchain, has remained in a narrow trading range for the past month, reflecting a bearish sentiment. The INJ price has entered a consolidation phase, signalling a lack of investor interest.

Injective also disclosed that Altaris will bring optimized network performance for developer tools. According to the blog post, the upgrade will integrate Wasm 2.0, expanding smart contract capabilities for software developers.

This upgrade, made possible by Injective Improvement Proposal 420 (IIP-420), represents a transformative leap forward for the platform. IIP-420 achieved remarkable support, with over $1 billion worth of staked $INJ voting in favor, reflecting one of the highest governance participation rates in Injective's history.

Injective (INJ)launches Altaris mainnet upgrade, promising enhanced scalability, new developer tools, and improved economic structure.

TL;DR Injective's Altaris upgrade has been approved with high participation from $INJ stakers. Upgrade deployment has begun, please refrain from making any transactions until it is complete. The upgrade includes improvements in scalability, real-world asset integration, and advanced smart contract capabilities.

Layer 1 (L1) blockchain Injective (INJ) will implement its highly anticipated Altaris mainnet upgrade in less than 24 hours.

Tria, the consumer-first modular chain abstraction platform, has expanded to the Injective blockchain network. INJ price was down 6% on Tuesday despite the positive development. On July 30, the Tria team announced the introduction of Unchained on Injective.

Injective Protocol (INJ) has demonstrated significant positive movement on its 3-day chart, gaining attention with its breakout from a falling wedge pattern. This technical formation, characterized by converging trendlines that slope downward, often precedes bullish reversals.

Crypto analyst Captain Faibik forecasts significant gains for DOT and INJ after key breakout patterns emerge.

Injective Protocol's native token, INJ, has experienced a notable decline of 18.77% over the past five days. As a layer-1 blockchain facilitating cross-chain transactions, Injective has garnered significant attention from investors.

Bitcoin (BTC) looks as though it may break out of the downward trend it has been in for 135 days. If this happens, certain altcoins could run hard.

INJ, the utility token of Injective, a layer-1 blockchain that allows trading across several chains, is down 18.77% in the last five days. In several instances, market participants will view this decline as a “buy the dip” opportunity.

There's been a recent market pullback despite the positive ETF inflows. Historical patterns suggest a brief pullback followed by a recovery. Bitcoin shows signs of a bullish divergence and reduced volume, suggesting a breakout. Solana and its ecosystem are performing well, with some tokens breaking weekly trends and showing strong growth potential.

TL;DR Mountain Protocol launches USDM on Injective, the ecosystem's first native yield-bearing stablecoin. USDM, backed by Treasury bonds, offers users an annualized yield of 5%. The integration enables USDM to be used as margin for derivatives trading on Injective, opening up new applications for asset tokenization.

Injective (INJ)has integrated with Mountain Protocol to launch USDM, a yield-bearing stablecoin, enhancing the DeFi ecosystem with tokenized treasury bills.

Injective, the blockchain for finance incubated by Binance and backed by prominent investors including Pantera, Jump Crypto, and Mark Cuban, has announced a key integration with Mountain Protocol.

Injective, a Cosmos Layer-1 blockchain for finance, said it has integrated with Mountain Protocol, the issuer of USDM, the yield-bearing stablecoin.

This partnership brings the innovative tokenized treasury instrument, USDY, into the Injective ecosystem. It paves the way for new institutional and Real-World Asset (RWA) use cases for $INJ.

Injective has announced a groundbreaking integration with OndoFinance. This partnership, which went live today, introduces new opportunities for institutional investors and expands the Real World Asset (RWA) offerings within the ecosystem.

Injective (INJ) has recently found itself at a critical crossroads. With the price encountering significant resistance at the $27.5 mark, investors and traders are keenly observing whether bullish momentum will prevail or if a potential pullback is on the horizon.

Despite the accumulation signal, the weakening short-term sentiment and demand hinted that a pullback could arrive soon.

Injective Protocol (INJ) has emerged as a notable player in the decentralized exchange (DEX) space, built on the Cosmos blockchain. As of July 2024, INJ is trading at $27.19, reflecting the dynamic interplay between technical indicators and broader market trends.